CleanSpace Holdings Limited (CSX.AX)
AUD 0.39
(-1.27%)
AUD 0.39
(-1.27%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -4.81 Million AUD | 59.98% |
| 2023 | -11.85 Million AUD | 21.67% |
| 2022 | -15.13 Million AUD | -194.48% |
| 2021 | 16.01 Million AUD | 139.72% |
| 2020 | 6.68 Million AUD | 464.21% |
| 2019 | -1.83 Million AUD | 19.56% |
| 2018 | -2.28 Million AUD | -11.24% |
| 2017 | -2.04 Million AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q4 | -842.37 Thousand AUD | 0.0% |
| 2024 Q1 | -1.56 Million AUD | 66.96% |
| 2024 FY | -4.74 Million AUD | 59.98% |
| 2024 Q2 | -3.12 Million AUD | -100.0% |
| 2024 Q3 | -842.37 Thousand AUD | 73.08% |
| 2023 Q4 | -4.73 Million AUD | -100.0% |
| 2023 FY | -11.85 Million AUD | 21.67% |
| 2023 Q3 | -2.36 Million AUD | 66.64% |
| 2023 Q2 | -7.09 Million AUD | -100.0% |
| 2023 Q1 | -3.54 Million AUD | 54.47% |
| 2022 Q4 | -7.79 Million AUD | -99.78% |
| 2022 Q1 | -3.65 Million AUD | -46.33% |
| 2022 FY | -15.13 Million AUD | -194.48% |
| 2022 Q3 | -3.9 Million AUD | 46.68% |
| 2022 Q2 | -7.31 Million AUD | -100.24% |
| 2021 Q1 | 9.2 Million AUD | 12.17% |
| 2021 Q4 | -2.49 Million AUD | -109.22% |
| 2021 Q3 | -1.19 Million AUD | -106.5% |
| 2021 Q2 | 18.36 Million AUD | 99.49% |
| 2021 FY | 16.01 Million AUD | 139.72% |
| 2020 Q4 | 8.2 Million AUD | 91.83% |
| 2020 Q2 | -1.24 Million AUD | -100.83% |
| 2020 FY | 6.68 Million AUD | 464.21% |
| 2020 Q1 | -618.12 Thousand AUD | 0.0% |
| 2020 Q3 | 4.27 Million AUD | 444.66% |
| 2019 FY | -1.83 Million AUD | 19.56% |
| 2018 FY | -2.28 Million AUD | -11.24% |
| 2017 FY | -2.04 Million AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| 4DMedical Limited | -27.96 Million AUD | 82.787% |
| Adherium Limited | -11.98 Million AUD | 59.834% |
| Aroa Biosurgery Limited | -9.78 Million AUD | 50.816% |
| Atomo Diagnostics Limited | -4.36 Million AUD | -10.375% |
| Anteris Technologies Ltd | -66.63 Million AUD | 92.775% |
| Control Bionics Limited | -5.92 Million AUD | 18.81% |
| CardieX Limited | -4.63 Million AUD | -3.89% |
| Compumedics Limited | -269 Thousand AUD | -1689.578% |
| Cochlear Limited | 521.5 Million AUD | 100.923% |
| Cyclopharm Limited | -9.22 Million AUD | 47.814% |
| EMVision Medical Devices Ltd | -1.61 Million AUD | -198.187% |
| Nova Eye Medical Limited | -3.79 Million AUD | -26.783% |
| HeraMED Limited | -6.42 Million AUD | 25.109% |
| Imricor Medical Systems, Inc. | -17.57 Million AUD | 72.61% |
| ImpediMed Limited | -19.03 Million AUD | 74.711% |
| InhaleRx Limited | -1.38 Million AUD | -247.206% |
| LBT Innovations Limited | -4.74 Million AUD | -1.56% |
| Micro-X Limited | -13.02 Million AUD | 63.046% |
| Neurotech International Limited | -5.58 Million AUD | 13.802% |
| OncoSil Medical Limited | -11.98 Million AUD | 59.831% |
| PolyNovo Limited | 1.16 Million AUD | 513.926% |
| Respiri Limited | -7 Million AUD | 31.231% |
| SomnoMed Limited | -3.84 Million AUD | -25.321% |
| Universal Biosensors, Inc. | -16.68 Million AUD | 71.14% |
| Uscom Limited | -2.4 Million AUD | -100.219% |
| Visioneering Technologies, Inc. | -5.85 Million AUD | 17.768% |